$37.01
0.772.12%
At Close: -
$37.11
0.10.27%
After Hours: 5:29 PM EDT
15 minutes delayed
Apellis Pharmaceuticals
APLSNASDAQ
Apellis Pharmaceuticals (APLS) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestApellis Pharmaceuticals (NASDAQ:APLS) Stock Quotes, Forecast and News Summary
Apellis Pharmaceuticals Stock (NASDAQ: APLS) stock price, news, charts, stock research, profile.
| Open | $36.62 |
| Close | $37.01 |
| Volume / Avg. | 1.29M / 1.47M |
| Day Range | 36.12 - 37.43 |
| 52 Wk Range | 19.83 - 90.21 |
| Market Cap | $4.50B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 41 |
| Short Interest | 15.83% |
| Days to Cover | 15.93 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Apellis Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Apellis Pharmaceuticals (APLS) stock?
You can purchase shares of Apellis Pharmaceuticals (NASDAQ:APLS) through any online brokerage.
Who are Apellis Pharmaceuticals (APLS) competitors?
Other companies in Apellis Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Alkermes (NASDAQ:ALKS) and TG Therapeutics (NASDAQ:TGTX).
What is the target price for Apellis Pharmaceuticals (APLS) stock?
There is no analysis for Apellis Pharmaceuticals.
What is the forecast for Apellis Pharmaceuticals (APLS) stock?
Apellis Pharmaceuticals has a consensus price target of $75.85.
Current stock price for Apellis Pharmaceuticals (APLS)?
The stock price for Apellis Pharmaceuticals (NASDAQ: APLS) is $37.11 last updated Today at July 8, 2024 at 5:29 PM EDT.
Does Apellis Pharmaceuticals (APLS) pay a dividend?
There are no upcoming dividends for Apellis Pharmaceuticals.
When is Apellis Pharmaceuticals (NASDAQ:APLS) reporting earnings?
Apellis Pharmaceuticals’s Q2 earnings are confirmed for Monday, July 29, 2024.
Is Apellis Pharmaceuticals (APLS) going to split?
There is no upcoming split for Apellis Pharmaceuticals.
What sector and industry does Apellis Pharmaceuticals (APLS) operate in?
Apellis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.